In this study, we found that EGCG significantly suppresses EMT, invasion and migration in anaplastic thyroid carcinoma (ATC) 8505C cells in vitro by regulating the TGF-β/Smad signaling pathways. The gene discussed is TGFB1; the disease is thyroid gland undifferentiated (anaplastic) carcinoma.